Provided by - WisMedical

Health tech startup WisMedical (CEOs Sung Hoon Lee and Woon-Hong Yeo) announced that it has been selected for the Innovation Award at the world's largest IT and tech expo to be held in Las Vegas, USA in January 2026.

WisMedical is a startup founded in 2022 in Atlanta, USA, as a spin-off from the Georgia Institute of Technology (hereinafter referred to as Georgia Tech). It is accumulating expertise in the field of sleep tech, which diagnoses sleep quality and sleep disorders by analyzing biosignals captured during sleep in real time.

In particular, the company explains that by developing a patch-type product that integrates and measures major bio-signals such as brain waves to resolve the complexity of equipment and sensors required for the existing polysomnography (PSG) method and building a sleep diagnosis platform that utilizes this, it will enable professional sleep monitoring even at home.

WisMedical's sleep monitoring platform, dubbed 'Tedream', is being evaluated for its excellent commercialization potential and market potential based on its simple hardware configuration, and has proven its global competitiveness by being selected for the Innovation Award in the Accessibility & Longevity category at the upcoming CES 2026.

WisMedical's Tedream is a platform that quantitatively measures various bio-signals such as ▲electroencephalogram (EEG) ▲eye movement (EOG) ▲oxygen saturation (SpO2) ▲electromyogram (EMG) ▲electrocardiogram (ECG) and snoring sounds with a single, ultra-light patch that is attached to the user's forehead, and analyzes the collected data with an AI (artificial intelligence) engine.

Analysis results include indicators such as sleep stages and sleep apnea index (AHI), and the breadth of data available significantly enhances analysis quality and reliability. Furthermore, it provides users with comprehensive insights to improve sleep quality, supporting proactive sleep habit and environment management. It also boasts high utility as data for accurate diagnosis by medical professionals.

In particular, the various devices such as multiple electrodes, cables, and analysis equipment used in the PSG method in hospitals and clinics can be replaced with a compact wireless patch and mobile app, making it easy to use at home. It also provides the effect of enabling more effective testing by reducing the user's stress due to measurement.

WisMedical aims to introduce the sleep monitoring platform selected for the Innovation Award as a next-generation healthcare-sleep tech solution, thereby further expanding its current collaboration with domestic and international hospitals and sleep health centers.

A company official said, “We are currently pursuing clinical validation of Tedream with major hospitals in the U.S. and the application of insurance coverage based on CPT codes, and we are expanding local partnerships in Japan and Europe to obtain medical device (PMDA·CE) approvals.” He added, “We also plan to commercialize Tedream as a home sleep diagnosis solution and long-term healthcare solution by exploring collaborations with global distributors and remote medical treatment platforms.”

He added, “In line with these goals, at CES 2026, we will actively communicate with medical device distributors, hospital networks, and digital healthcare investors in the U.S. and the European Union (EU) to identify new business opportunities.”

Reporter Nam Seung-hyun
cxsh@aving.net

Published 2025.12.03

https://kr.aving.net/news/articleView.html?idxno=1806758